Aoxing Pharmaceutical Company, Inc.  

(Public, NYSEMKT:AXN)   Watch this stock  
Find more results for NYSEAMEX:AXN
0.510
+0.064 (14.35%)
Apr 23 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.39 - 0.53
52 week 0.19 - 0.72
Open 0.42
Vol / Avg. 201,144.00/43,681.00
Mkt cap 25.44M
P/E     -
Div/yield     -
EPS -0.35
Shares 49.87M
Beta 2.20
Inst. own 0%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -55.31% -159.66%
Operating margin -19.12% -131.32%
EBITD margin - -50.19%
Return on average assets -19.51% -40.77%
Return on average equity -286.86% -121.99%
Employees 589 -
CDP Score - -

Address

Suite 3338, 444 Washington Blvd
JERSEY CITY, NJ 07310
United States - Map
+1-646-3671747 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aoxing Pharmaceutical Company, Inc. (Aoxing Pharma), is a pharmaceutical company, which specializes in research, development, manufacturing and distribution of a variety of narcotics and pain-management products and drug-relief medicine. The Company has one operating subsidiary, Hebei Aoxing Pharmaceutical Co., Inc. (Hebei Aoxing).Hebei Aoxing is engaged in developing narcotics and pain management products. The Company owns 95% of the equity in Hebei Aoxing. The Company's product offerings include Zhongtongan,Bismuth Potassium Citrate,Xiaopiling, and Naloxone Hydrochloride.

Officers and directors

Zhenjiang Yue Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Guoan Zhang Acting Chief Financial Officer, Senior Vice President - Finance
Age: 43
Bio & Compensation  - Reuters
Guirong Zhou President - Research and Development
Age: 58
Bio & Compensation  - Reuters
Jun Min Director
Age: 53
Bio & Compensation  - Reuters
Yang Li Independent Director
Age: 33
Bio & Compensation  - Reuters
Guozhu Xu Independent Director
Age: 67
Bio & Compensation  - Reuters